Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of General Virology

• Publication date

  1999-12-01

• Fields of study

  Agricultural and Food Sciences, Medicine, Biology

• Identifiers
  DOI 10.1099/0022-1317-80-12-3137PMID 10567644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation).

  2010cited by this paper
• The 5′-untranslated region sequence of a potential new genotype of bovine viral diarrhea virus

  2005cited by this paper
• Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease

  2005cited by this paper
• Immunization with DNA vaccines in early life: Advantages and limitations as compared to conventional vaccines

  2004cited by this paper
• Investigation of the immunological properties of the bovine viral diarrhea virus protein NS3 expressed by an adenovirus vector in mice

  1999cited by this paper
• Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle.

  1998cited by this paper
• Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus.

  1998cited by this paper
• Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus.

  1998cited by this paper
• Protection of pigs against Aujeszky's disease by DNA vaccination.

  1997cited by this paper
• Immunization of non-human primates with DNA vaccines.

  1997cited by this paper
• A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge.

  1997cited by this paper
• Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2).

  1997influential reference
• DNA vaccines.

  1997cited by this paper
• DNA immunization.

  1996cited by this paper
• Control of bovine viral diarrhea infection by use of vaccination.

  1995cited by this paper
• CERTAlN FACTORS TO CONSIDER WHEN DESIGNING A BOVINE VACCINATION PROGRAM

  1995cited by this paper
• Molecular Biology of Bovine Viral Diarrhea Virus and its Interactions with the Host

  1995cited by this paper
• Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities.

  1994influential reference
• Segregation of bovine viral diarrhea virus into genotypes.

  1994influential reference
• Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

  1994cited by this paper
• Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

  1994cited by this paper
• Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

  1993cited by this paper
• Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA

  1993cited by this paper
• Correlation of bovine viral diarrhoea virus induced cytopathic effects with expression of a biotype-specific marker.

  1991cited by this paper
• Pestiviruses--taxonomic perspectives.

  1991cited by this paper
• The current understanding about the pathogenesis and clinical forms of BVD

  1990cited by this paper
• Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus.

  1988cited by this paper
• Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein.

  1988cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without the administration of ACTH.

  1983influential reference
• Diffusion of univalent ions across the lamellae of swollen phospholipids.

  1965cited by this paper

• Circulating T cell subpopulations in dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 following modified-live virus booster vaccination: Effects of the administration route and trace mineral supplementation.

  2025cites this paper
• Effects of injectable trace minerals (Se, Zn, Cu, and Mn) administration on the immune response elicited by primary intranasal modified-live virus vaccination in dairy calves

  2025cites this paper
• Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus

  2024cites this paper
• The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine

  2023cites this paper
• Sağlık Alanında Yenilikçi Bir Yaklaşım: Nanopartiküller/Nanotıp

  2022cites this paper
• Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses

  2022cites this paper
• Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.

  2022cites this paper
• An Assessment of Secondary Clinical Disease, Milk Production and Quality, and the Impact on Reproduction in Holstein Heifers and Cows from a Single Large Commercial Herd Persistently Infected with Bovine Viral Diarrhea Virus Type 2

  2020cites this paper
• Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis

  2020cites this paper
• Immune response and onset of protection from Bovine viral diarrhea virus 2 infection induced by modified-live virus vaccination concurrent with injectable trace minerals administration in newly received beef calves

  2020cites this paper
• Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by Lactobacillus casei Effectively Induces Antigen-Specific Immune Responses via Oral Vaccination

  2019cites this paper
• Nano-formulations for Diagnostics and Therapeutics of Foot-and-Mouth Disease in Animals

  2019cites this paper
• Effects of injectable trace minerals administered concurrently with a modified live virus vaccine on long-term protection against bovine viral diarrhea virus acute infection in dairy calves.

  2018cites this paper
• Pestivirus infection in cattle dairy farms: E2 glycoprotein ELISA reveals the presence of bovine viral diarrhea virus type 2 in northwestern Italy

  2017cites this paper
• Erratum to: Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle

  2016cites this paper
• Characterisation of T cell responses to bovine viral diarrhoea virus proteins and its applications towards the development of improved vaccines

  2015cites this paper
• Challenges in Veterinary Vaccine Development and Immunization

  2015cites this paper
• Expression of E2 gene of bovine viral diarrhea virus in Pichia pastoris: a candidate antigen for indirect Dot ELISA.

  2015cites this paper
• A molecular epidemiological study on Haemorrhagic septicaemia disease in Pakistan

  2014cites this paper
• Principales sistemas de entrega de antígenos en Medicina Veterinaria y Humana

  2014cites this paper
• Carrier molecules for use in veterinary vaccines.

  2013cites this paper
• An Overview on Applications of Nanoparticles in Biological Systems

  2013cites this paper
• Nanomedicine and veterinary science: the reality and the practicality.

  2012cites this paper
• Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle

  2012cites this paper
• Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status

  2012cites this paper
• Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV.

  2012cites this paper
• Adjuvants and delivery systems in veterinary vaccinology: current state and future developments

  2011cites this paper
• Characterization of recombinant BVDV-2 vaccine prototypes based on packaged replicons and replication competent deletion mutants

  2010cites this paper
• Évaluation de stratégies pour l'optimisation d'un vaccin à ADN contre le virus de la diarrhée virale bovine (BVDV)

  2009cites this paper
• Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.

  2009cites this paper
• Development and validation of an ELISA for quantitation of bovine viral diarrhea virus antigen in the critical stages of vaccine production.

  2009cites this paper
• Perspectivas para o controle do vírus da diarréia viral Bovina (BVDV)

  2009cites this paper
• Perspectives to control Bovine Viral Diarrhea Virus (BVDV)

  2009cites this paper
• Perspectivas para el control del Virus de la Diarrea Viral Bovina (BVDV)

  2009cites this paper
• Establishment of a Bovine Herpesvirus 4 based vector expressing a secreted form of the Bovine Viral Diarrhoea Virus structural glycoprotein E2 for immunization purposes

  2007cites this paper
• Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.

  2007cites this paper
• Expression of the surface glycoprotein E2 of Bovine viral diarrhea virus by recombinant vesicular stomatitis virus.

  2007cites this paper
• Bovine viral diarrhoea virus (BVDV) diversity and vaccination. A review

  2007cites this paper
• Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.

  2007cites this paper
• Control of Bovine Viral Diarrhoea Infections Through Vaccination

  2007cites this paper
• DNA vaccines and prevention of infectious diseases in bovines: A review

  2007cites this paper
• Expression of Bovine Viral Diarrhea Virus Glycoprotein E2 as a Soluble Secreted Form in a Mammalian Cell Line

  2006cites this paper
• Molecular and immunogenic analysis of Jembrana disease virus Tat

  2006cites this paper
• Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle.

  2006cites this paper
• Particulate delivery systems for animal vaccines.

  2006cites this paper
• Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.

  2005cites this paper
• Molecular characterisation of bovine viral diarrhoea virus with special regard to cytopathogenicity

  2005cites this paper
• Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.

  2005influential citation
• Fusion to C3d Enhances the Immunogenicity of the E2 Glycoprotein of Type 2 Bovine Viral Diarrhea Virus

  2004cites this paper
• The immune response to bovine viral diarrhea virus: a constantly changing picture.

  2004cites this paper
• [Vaccines against infection with bovine viral diarrhea virus/mucosal disease (BVDV/MD): a short overview].

  2003cites this paper
• DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge.

  2003influential citation
• Microparticles and nanoparticles as delivery systems for DNA vaccines.

  2003cites this paper
• DNA vaccines: new applications for veterinary medicine

  2001influential citation
• [DNA vaccines for veterinary medicine].

  2001cites this paper
• A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever.

  2001cites this paper
• Microparticle-mediated RNA immunization against bovine viral diarrhea virus.

  2001cites this paper
• Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice.

  2001cites this paper
• Immunostimulatory CpG‐modified plasmid DNA enhances IL‐12, TNF‐α, and NO production by bovine macrophages

  2001cites this paper
• CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice.

  2001cites this paper
• Evaluation of genetic vaccine against classical swine fever.

  2001cites this paper
• Avancées récentes en biologie moléculaire du virus de la diarrhée virale bovine

  2001cites this paper
• Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats.

  2000cites this paper
• Nucleic acid vaccines: research tool or commercial reality.

  2000cites this paper